Final warning from NPPA to pharmacy companies those failing to register under IPDMS & filing mandatory forms as per DPCO

  • News
  • September 17, 2017

The National Pharmaceutical Pricing Authority (NPPA) is ready to take strict actions against who still not followed various instructions issued regarding submissions of filled forms in IPDMS including notices released on 03 August 2016 and 12 January 2017 to all pharmaceutical companies. These issues posted to inform pharmaceutical companies to register themselves in IPDMS and also to file all mandatory forms as provided in Drug (Prices Control) Order, 2013 (DPCO, 2013) through IPDMS, but still a number of companies ignored them.

NPPA now finally warned pharma companies otherwise they will take action under EC Act for failing to register under IPDMS & filing mandatory forms as per DPCO. NPPA received a number of responses from companies, yet they were not exceptionally reassuring, notwithstanding different notification and gatherings. NPPA again issued an O.M of even no. dated 01.02.2017, wherein consistency on IPDMS was made an essential for consideration of the representations of the companies for retail price approvals, discontinuation of drugs and in respect of draft calculation sheets (before warning).

The observations made by NPPA that many companies still ignoring the issues like companies still submitting the requisite Forms in physical mode, even though the NPPA instructed that forms submitted through physical mode will not be taken into consideration after 01.09.2016.  Many companies, even after receiving many instructions still not filed the Form II as per WPI reduction effective from 01.04.2016 and Form-Ill and Form-V through IPDMS.

NPPA also observed, only marketing companies are documenting the essential forms, while the forms are to be submitted by “manufacturers” as characterized under para 2(n) of DPCO 2013, which indicates manufacturers also. Such IPDMS filings should be considered as incomplete in the context of O.M of even no. dated 01.02.2017.

As the companies did not follow NPPA directions, the NPPA released a list of 634 pharmacy companies by looking at the detailed submissions, who had not enlisted in IPDMS. These companies were instructed to enroll themselves on IPDMS and document every single compulsory form as required under DPCO, 2013 vide O.M dated 01.05.2017.

NPPA also said, if companies find any issues related to registration or filing of forms in IPDMS, then they can contact them on telephone number (011-23360265) of the office between 1.30 pm to 3.30 pm and can also email the problems (if any) to nppa@nic.in or dir-me.nppa@nic.in

  • Related Posts

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

    Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Indian Pharma Majors Plan to Invest in US

    Indian Pharma Majors Plan to Invest in US

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

    Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

    National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

    World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

    World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification